secwatch.observer — SEC 8-K summary
======================================

Issuer:     Petros Pharmaceuticals, Inc. (PTPI)
CIK:        0001815903
Form:       8-K
Filed at:   2024-11-21T23:59:59+00:00
Accession:  0001104659-24-121603
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Petros Pharma stockholders OK reverse stock split up to 1:25
------------------------------------------------------------

- Directors Silverman, Bernstein, Walker elected to one-year terms.
- Reverse stock split (range 1:2 to 1:25, Board discretion) approved; For 2,949,518, Against 1,350,781.
- Marcum LLP ratified as independent auditor for FY2024 with 3,984,099 for votes.
- Advisory say-on-pay proposal passed with 1,433,687 for votes.
- Adjournment proposal passed to allow further proxy solicitation if needed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1815903/000110465924121603/0001104659-24-121603-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1815903/000110465924121603/tm2429163d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-121603

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer